drugset / Trial / NCT05005065
Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate pharmacokinetics/pharmacodynamics and safety/tolerability of IN-C005 and IN-A001 after oral administration in healthy Caucasian subjects.
Timeline
- Start
- 2021-09-06
- Primary completion
- 2021-11-18
- Completion
- 2021-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IN-A001 | Unknown | 100 mg | Oral |
| Subject | IN-C005 | Unknown | 50 mg | Oral |
| Subject | IN-C005 | Unknown | 75 mg | Oral |
| Subject | IN-C005 | Unknown | 100 mg | Oral |
Indications
No indication recorded.